• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-RhoGDI

RhoGDI Monoclonal Antibody for WB, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, rat, souris

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1B1G9

N° de cat : 66480-1-PBS

Synonymes

aGDI, ARHGDIA, GDIA1, Rho GDI 1, Rho GDI alpha, RHOGDI, RHOGDI 1



Informations sur le produit

66480-1-PBS cible RhoGDI dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène RhoGDI Protéine recombinante Ag0791
Nom complet Rho GDP dissociation inhibitor (GDI) alpha
Masse moléculaire calculée 28 kDa
Poids moléculaire observé 28 kDa
Numéro d’acquisition GenBankBC005851
Symbole du gène RhoGDI
Identification du gène (NCBI) 396
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Rho GDP-dissociation inhibitor (RhoGDI), also called ARHGDIA, is one member of ARHGDIs, which is ubiquitously expressed and interacts with several Rho GTPases, mainly including RhoA, Rac1, and Cdc42. RhoGDI can inhibit nucleotide exchange and membrane association to downregulate the activities of Rho family GTPase. It is overexpressed in various human cancers. Activity of this protein is important in a variety of cellular processes, and it is overexpressed in various human cancers. Mutations in RhoGDI have been found in individuals with nephrotic syndrome, type 8.

{{ptg:RelatedPrimaryAntibodies}}